Price
$70.91-4.59%Social Signal Score
Analyst Ratings
33 analysts52-week range
- Last close
- $70.91
- Off 52w high
- -13.4%
- 200-day average
- $74.31
- vs 200-day
- -4.6%
Revenue
$213.88M+745.46%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Joel N. Agree
- Sector
- Real Estate
- Industry
- REIT - Retail
- Employees
- 90
- Beta
- 0.39
- Country
- US
- Piotroski score
- 6 / 9 (Middling)
- Altman Z-score
- 1.48
Financials
Revenue
$213.88M+745.5%Net Income
$68.35M+436.8%EBITDA
$181.83M+766.4%Free Cash Flow
$136.52M+384.2%EPS (diluted)
$0.53+6.0%Shares Outstanding (diluted)
124.60M+389.2%Operating Expenses
$12.39MCash & Debt
$80.56MReturn of Capital
$101.58MDividend per Share
$0.27Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $718.40M | $204.35M | $1.77 |
| 2024 | $617.10M | $189.20M | $1.79 |
| 2023 | $537.50M | $169.96M | $1.70 |
| 2022 | $429.81M | $152.44M | $1.84 |
| 2021 | $339.32M | $122.27M | $1.79 |
| 2020 | $248.57M | $91.38M | $1.76 |
| 2019 | $187.48M | $80.08M | $1.96 |
| 2018 | $137.12M | $58.17M | $1.81 |
| 2017 | $111.52M | $58.11M | $2.09 |
| 2016 | $91.53M | $45.12M | $1.97 |
| 2015 | $69.97M | $39.02M | $2.17 |
| 2014 | $53.56M | $18.49M | $1.24 |
| 2013 | $43.52M | $19.68M | $1.51 |
| 2012 | $34.62M | $18.05M | $1.63 |
Valuation
Project earnings forward and see what return today's price implies.
Seeded from ADC's reported EPS growth of 0.6% a year over 13 years.
- EPS in 5 years
- $1.90
- Implied price
- $77.97
- Return from $70.91
- 1.9% a year
To earn 15.0% a year on these assumptions you'd need to buy at $38.76 — -45.3% below today's price.
How sensitive is that answer?
Annual return across nearby assumptions. If the result is only attractive in one corner, that is the finding.
| growth \ P/E | 29 | 35 | 41 | 47 | 53 |
|---|---|---|---|---|---|
| -9.4% | -14.4% | -11.1% | -8.2% | -5.7% | -3.4% |
| -4.4% | -9.6% | -6.2% | -3.1% | -0.5% | 2.0% |
| 0.6% | -4.9% | -1.3% | 1.9% | 4.7% | 7.3% |
| 5.6% | -0.2% | 3.6% | 7.0% | 9.9% | 12.6% |
| 10.6% | 4.5% | 8.6% | 12.0% | 15.1% | 17.9% |
This is arithmetic on assumptions you chose, not a forecast or a recommendation. It ignores dividends, buybacks, share issuance and debt, and it assumes a company still earning money in 5 years. Change any input and the answer changes a lot — that sensitivity is the honest result, not a flaw in the model.
Signal Score (90d)
30-60.00%Social Signal Score
Mentions (100)
- News247wallst.com·13h ago·Negative
5 Monthly Dividend Payers to Own Heading Into December Each of these stocks pays every month, and each has its December check already declared.
View source ↗ - Newsseekingalpha.com·1d ago·Positive
I Wouldn't Dare Retire Without These 3 Dividend Machines Retiring on dividends requires more than just high yields. Without recession-resistant cash flows and inflation-beating dividend growth, even a seemingly attractive retirement portfolio could fail when investors need it most. I share three investments that offer particularly compelling combinations of attractive current income, defensive business models, and long-term dividend growth potential, making them foundational holdings for retirem
View source ↗ - 4chan /biz/biz·1d ago·Neutral
>>62943481 Agree.
View source ↗ - News (RSS)zerohedge·1d ago·Negative
Democrats And Republicans Actually Agree On Something Democrats And Republicans Actually Agree On Something If there's one thing Republicans and Democrats, especially those from auto-producing states, can agree on, it appears to be banning cheap Chinese cars from American highways. Bloomberg cites sources who say bipartisan lawmakers are planning to send a bill to President Trump's desk by the end of the year to ban Chinese automakers, such as BYD Co. and Geely Automobile Holdings, from the US m
View source ↗ - 4chan /biz/biz·1d ago·Neutral
>>62943063 Agree but how can everyone afford future AI is a big question
View source ↗ - Newsprnewswire.com·3d ago·Negative
Biohaven's Novel FGFR3-Directed ADC with Proprietary TopoIx Payload, BHV-1530, Shows Clinical Activity and Confirmed Responses in FGFR3-Altered Urothelial and Head and Neck Cancers, Oral Presentation at ENA 2026 Phase 1 data presented in an oral plenary session at the 38th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics (ENA 2026) in Barcelona, Spain, showed deep and durable responses in patients with FGFR3-altered urothelial cancer (UC) and head and neck squamous cell carc…
View source ↗ - News (RSS)zerohedge·4d ago·Negative
Neocon Fox News Host Goes Mask-Off With Stunning Attack On JD Vance Neocon Fox News Host Goes Mask-Off With Stunning Attack On JD Vance Fox News host Brian Kilmeade let his neoconservative mask slip, launching a blistering attack on Vice President JD Vance over his opposition to another prolonged war in the Middle East.The longtime Fox & Friends co-host used his radio show to declare that Vance never should have made it to the vice presidency, apparently taking exception to the vice president's
View source ↗ - News247wallst.com·4d ago·Neutral
Realty Income and 2 More Monthly Dividend Stocks Built for Retirement Income A monthly payout means little if it vanishes in a downturn. Three monthly payers earned a spot by passing tests on coverage and balance sheets first, yet each one hides a different risk that retirees should watch before trusting the check.
View source ↗ - Newsseekingalpha.com·5d ago·Neutral
If I Could Only Retire On 2 REITs, I'd Buy These Not all high-yielding REITs are suitable for retirees. Net lease REITs offer predictable income and steady dividend growth. Two high-quality REITs stand out despite today's market uncertainty.
View source ↗ - News (RSS)zerohedge·11d ago·Neutral
Blackouts Reveal How Fragile Society Really Is Blackouts Reveal How Fragile Society Really Is Authored by John Walter via John Walter,"Long-term blackout" gets used loosely enough that people end up arguing past each other, and the confusion deepens because a week without power is a bad camping trip for somebody in rural Maine with a generator and a wood stove while being an outright catastrophe for a family on the fourteenth floor of a Miami condo with an insulin-dependent nine-year-old. Both r
View source ↗ - 4chan /biz/biz·11d ago·Negative
>>62885667 China did have the AI bubble pop, stocks dropped 1.3t, mainly AI. Im not sure they are as cost effective as you think. Agree with the rest. Out of curiosity I asked as its a good question. Hiding and Securing Reasoning Traces: Distillation campaigns rely heavily on capturing step-by-step Chain-of-Thought (CoT) tokens. Anthropic and others stopped exposing raw, unsummarized reasoning transcripts and patched prompt-injection tricks that extract reasoning across sessions. Anti-Distilla
View source ↗ - Newsprnewswire.com·13d ago·Neutral
ADC Therapeutics Reports Third Quarter 2026 Financial Results and Provides Operational Updates Third quarter 2026 net product revenue of $21 million; cash and cash equivalents of $189.2 million as of September 30, 2026 Strategic financial restructuring strengthens balance sheet, extending expected cash runway into 2029 Abstracts accepted for presentation at ASH 2026, highlighting ZYNLONTA's potential across multiple B-cell malignancies Tanabe's marketing authorization application filing and subl…
View source ↗ - News (RSS)seekingalpha·14d ago·Neutral
ADC Therapeutics SA (ADCT) Discusses ZYNLONTA Data at ASH and Strategic Financial Restructuring - Slideshow
View source ↗ - 4chan /biz/biz·16d ago·Neutral
>>62869529 Agree. Oh well, sucks for him. Imagine 5600% and throwing it all away
View source ↗ - 4chan /biz/biz·16d ago·Positive
>>62866623 Agree. But you wont have to wait long friend. It's pumping tomorrow
View source ↗ - News (RSS)bbc·16d ago·Neutral
Nigerian court rules opposition candidate cannot stand in elections The high court has sacked the leadership of the opposition ADC party with only months to go until elections.
View source ↗ - News (RSS)economictimes·17d ago·Neutral
Trump’s pain makes D-Street bulls gain! IndiGo, Asian Paints, other crude-sensitive stocks rally up to 8% as oil drops below $95 Shares of paint makers, airlines, tyre manufacturers and oil marketing companies (OMCs) rallied up to 8% on Thursday as oil prices plunged nearly 10%, falling below $100 per barrel after weeks. The decline came amid a major setback for US President Donald Trump, whose Republican Party lost control of both houses of Congress in the midterm elections.Brent crude futures
View source ↗ - Newsmarketbeat.com·18d ago·Negative
ADC Therapeutics Reports Strong Lymphoma Responses, Plans Phase III Study ADC Therapeutics NYSE: ADCT outlined new lymphoma data and plans for further studies of its cancer drug ZYNLONTA, while reporting preliminary third-quarter sales of approximately $21 million and an expected cash runway into 2029.
View source ↗ - News247wallst.com·18d ago·Positive
4 Monthly Dividend Stocks That Could Pay You Like Clockwork in Retirement Most dividend stocks pay quarterly, leaving retirees to juggle bills against an awkward schedule.
View source ↗ - News (RSS)nakedcapitalism·18d ago·Neutral
Hannah Arendt on the Power of Friendship in a Broken World We have previously discussed Hannah Arendt (1906-1975) in Hannah Arendt, Isaiah Berlin and the Tenor of Our Time. Agree with her or not, she is always a good teacher, and at all times we must choose our teachers carefully. I started reading her work shortly after her death and have kept at it ever since. […]
View source ↗ - Newsseekingalpha.com·18d ago·Positive
Hard To Imagine A Retirement Portfolio Without These 2 Dividend Machines Retiring on dividends comes down to two things: income you can count on and returns that make saving easier. Since those two goals pull against each other, I use a specific payout and cash-flow test to find the right balance. That test leaves out many popular dividend names but highlights two businesses built for decades of steady income.
View source ↗ - Newsprnewswire.com·18d ago·Negative
ADC Therapeutics Announces Abstracts at the 68th ASH Annual Meeting Highlighting Breadth of ZYNLONTA® Clinical Program ZYNLONTA data to be featured across 5 oral presentations and multiple posters Phase 1b LOTIS-7 abstract data demonstrates an 88.7% ORR and 75.3% CR with ZYNLONTA plus glofitamab across the 97 efficacy-evaluable r/r DLBCL patients Phase 2 marginal zone lymphoma IIT abstract shows robust and durable 93% ORR and 74.4% CRR with ZYNLONTA monotherapy Company to host conference call to…
View source ↗ - News (RSS)zerohedge·19d ago·Negative
US-Iran Reportedly Agree To Concessions On Nuclear File, Oil Plunges US-Iran Reportedly Agree To Concessions On Nuclear File, Oil Plunges Update(0835ET): US-Iran headlines are once again swinging between mediator proposals and Tehran declaring it is "now in a state of war" after the Qeshm strike - which is a sadly all too familiar pattern from this past summer. The latest from regional sources are seeing oil prices drop lower:"Washington has approved the draft memorandum of understanding that th
View source ↗ - News247wallst.com·19d ago·Neutral
Realty Income Just Raised Its Dividend Again. Here Are 2 More Monthly Payers Most dividend stocks make you wait three months between payments, but a small group of NYSE companies cut those checks every single month and keep raising the amount. Three of them clear every safety bar worth checking.
View source ↗ - News (RSS)seekingalpha·19d ago·Negative
Agree Realty: A Dividend Hike As Treasury Rates Surge (Rating Downgrade)
View source ↗ - Newsprnewswire.com·19d ago·Negative
ADC Therapeutics to Present at November Investor Conferences LAUSANNE, Switzerland, Nov. 3, 2026 /PRNewswire/ -- ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs), today announced participation in two upcoming investor conferences in November: Guggenheim Third Annual Healthcare Innovation Conference Date: Tuesday, November 10, 2026Presentation Time: 1:30 p.m. ESTFormat: Fireside ChatSpeaker: Ameet Mallik, Chief Executiv…
View source ↗ - Newsseekingalpha.com·19d ago·Neutral
Agree Realty: A Dividend Hike As Treasury Rates Surge (Rating Downgrade) Agree Realty has dipped as rising Treasury yields pressure both common and preferred shares despite a strong third-quarter performance. ADC's 4.81% dividend yield now trails the U.S. 10-year Treasury, which would dampen investor enthusiasm for the security. Strong leasing, investment-grade tenants, and a fortress balance sheet underpin ADC's long-term bull case, but higher funding costs pose near-term risks.
View source ↗ - Newsbusinesswire.com·20d ago·Neutral
Aarvik Therapeutics Announces Milestone Achievement, Partnership Update, and Presentations on MUTTA™ and AQUALINK™ Platforms at the 17th Annual WADC Conference HAYWARD, Calif.--(BUSINESS WIRE)-- #biotechnology--Aarvik Therapeutics (Aarvik), an innovative, ADC-focused biotechnology company dedicated to engineering precision medicines for cancer therapy, is pleased to announce important updates to its partnership efforts. Dosing of the first patient in a Phase 1 trial in the US for AV-P138-ADC (AR…
View source ↗ - Newsprnewswire.com·20d ago·Negative
ADC Therapeutics Announces New Employee Inducement Grant LAUSANNE, Switzerland, Nov. 2, 2026 /PRNewswire/ -- ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs), today announced that the Company has made a grant of options to purchase an aggregate of 17,000 of the Company's common shares to a new employee on November 2, 2026. ("Grant").
View source ↗ - Newsprnewswire.com·20d ago·Negative
ADC Therapeutics to Announce Third Quarter 2026 Financial Results on November 9, 2026 LAUSANNE, Switzerland, Nov. 2, 2026 /PRNewswire/ -- ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs), today announced that the Company will report full financial results for the third quarter of 2026 through a press release on Monday, November 9, 2026. The press release will be available in the News section of the Company's website, h…
View source ↗ - News247wallst.com·21d ago·Positive
The 10-Year Treasury Yield Fell 33 Basis Points. Here Are 5 Net-Lease REITs to Watch Long-term Treasury yields just pulled back sharply, and net-lease REITs stand to benefit more than almost any other corner of real estate.
View source ↗ - Newsseekingalpha.com·22d ago·Neutral
If I Could Only Buy 3 REITs After The Sell-Off REITs have sold off despite many maintaining strong fundamentals. Some blue-chip REITs now offer unusually attractive valuations and yields. Accelerating rent growth and lower rates could drive significant upside.
View source ↗ - News247wallst.com·23d ago·Positive
Realty Income and Agree Realty Both Raised Guidance. Which Dividend Looks Stronger? Two monthly dividend REITs both raised guidance this year, but one is charging into data centers while the other is pulling back on deals to guard its balance sheet.
View source ↗ - Newsglobenewswire.com·23d ago·Positive
Akari Therapeutics to Highlight Novel RNA-Splicing ADC Payload Strategy at the 3rd Annual ADC Payload Summit Presentation to explore the potential of RNA-splicing payloads to drive broad anti-tumor effects through direct cell killing along with immune activation
View source ↗ - News (RSS)investing·24d ago·Neutral
ADC Therapeutics partner files for Japan approval of ZYNLONTA
View source ↗ - Newsprnewswire.com·24d ago·Negative
ADC Therapeutics Announces ZYNLONTA® Updates in Japan Licensing partner, Tanabe Pharma, filed for Japanese approval of ZYNLONTA (MT-2111) for relapsed or refractory DLBCL based on encouraging Japanese Phase 1/2 clinical results Tanabe Pharma entered into exclusive sublicensing agreement with Nippon Shinyaku, bringing established Japanese oncology expertise and commercial capabilities to support potential introduction in Japan Supports anticipated regulatory and commercial milestones for ADC Ther…
View source ↗ - Newsseekingalpha.com·24d ago·Positive
Undercovered Dozen: Micron, i-80 Gold, Hercules Capital, And More The Undercovered Dozen highlights 12 lesser-covered stocks with actionable investment theses and recent catalysts. Featured companies include i-80 Gold, Hercules Capital, and Aya Gold & Silver, each rated Buy or Strong Buy for unique growth or yield drivers. Several stocks, such as Corning and AeroVironment, are rated Hold, with valuation and risk concerns tempering bullish sentiment despite recent price declines.
View source ↗ - News (RSS)seekingalpha·25d ago·Neutral
Zai Lab Limited (ZLAB) Discusses Phase 1 Study Results of DLL3-Targeted ADC ZL-1310 in Small Cell Lung Cancer - Slideshow
View source ↗ - Newsseekingalpha.com·27d ago·Neutral
Agree Realty: Not Much Has Changed Except A Better Entry Point Agree Realty offers a compelling entry point for long-term income investors at 14x AFFO and a near 5% yield. ADC's robust balance sheet, a credit rating of 'A,' and conservative payout ratio position it well amid higher rates and sector volatility. Despite lowered investment guidance, ADC's acquisition discipline, capital recycling, and record development activity support stable, long-term cash flows.
View source ↗ - Newsseekingalpha.com·28d ago·Neutral
REITs Rebound As Earnings Deliver U.S. markets remained unsettled as cracks emerged in the AI investment boom, while another oil-price surge complicated the inflation outlook ahead of Wednesday's Fed decision. Treasury yields fell for a third straight week as AI-related risk-off flows strengthened, with markets now assigning just 10% odds of an October hike despite still-elevated energy prices. REITs rallied for a third-straight week as earnings opened on an encouraging note: 15 REITs raised ful
View source ↗ - Newsglobenewswire.com·28d ago·Negative
ArriVent Announces Initial Phase 1 Data for CDH17-targeted ADC ARR-217 in Patients with Gastrointestinal Cancers at ESMO Congress 2026 NEWTOWN SQUARE, Pa., Oct. 25, 2026 (GLOBE NEWSWIRE) -- ArriVent BioPharma, Inc. (Company or ArriVent) (Nasdaq: AVBP), a clinical-stage company dedicated to accelerating the global development of innovative biopharmaceutical therapeutics, today announced initial encouraging Phase 1 results for ARR-217, (MRG007), a cadherin-17 (CDH17)-targeting antibody-drug conjug…
View source ↗ - News (RSS)seekingalpha·29d ago·Neutral
Zymeworks early-stage results on ADC show anti-tumor activity in ovarian cancer
View source ↗ - News (RSS)seekingalpha·29d ago·Neutral
Eli Lilly releases promising early-stage data on ADC for ovarian cancer
View source ↗ - News (RSS)financialpost·29d ago·Negative
BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 2026 Potential first-in-class GPC3 x 4-1BB bispecific achieves a 36% confirmed response rate at Phase 3 dose and favorable safety profile in heavily pretreated liver cancer Brain-penetrant PRMT5 inhibitor shows promising antitumor and CNS activity in the largest publicly shared MTAP-deficient dataset First clinical data of CEA-targeting ADC demonstrates encouraging and sustained responses in CEAhigh NSCLC […]
View source ↗ - Newsgurufocus.com·29d ago·Neutral
Bio-Thera Announces Promising Clinical Data for BAT8008 in Combination with BAT1308 in First-Line Non-Small Cell Lung Cancer at ESMO 2026 Bio-Thera Announces Promising Clinical Data for BAT8008 in Combination with BAT1308 in First-Line Non-Small Cell Lung Cancer at ESMO 2026PR NewswireGUANGZHOU, C
View source ↗ - Newsprnewswire.com·29d ago·Negative
Lilly presents first clinical data in platinum-sensitive ovarian cancer for its investigational, next-generation, FRα-targeting ADC at ESMO 2026 Sofetabart mipitecan (Sofe-M) in combination with bevacizumab demonstrated a 79% confirmed objective response rate and 100% disease control rate, with similar activity observed across FR α expression levels Clinical activity with Sofe-M was maintained even in patients with prior PARP inhibitor exposure, patients who typically experience poor outcomes wi…
View source ↗ - Newsglobenewswire.com·30d ago·Neutral
ArriVent to Present Initial Phase 1 Data for CDH17-targeted ADC ARR-217 in Patients with Gastrointestinal Cancers at the ESMO Congress 2026 NEWTOWN SQUARE, Pa., Oct. 23, 2026 (GLOBE NEWSWIRE) -- ArriVent BioPharma, Inc. (Company or ArriVent) (Nasdaq: AVBP), a clinical-stage company dedicated to accelerating the global development of innovative biopharmaceutical therapeutics, today announced that initial safety and efficacy data from the Phase 1 (NCT07066657) study of CDH17-targeted ADC ARR-217 (…
View source ↗ - 4chan /biz/biz·31d ago·Neutral
>>62806608 Meh, we are the board and I dont mind during trading hours. Agree after market.
View source ↗ - Newsseekingalpha.com·31d ago·Neutral
Agree Realty: The Selloff Has Created An Attractive Income Opportunity Agree Realty Corporation remains a Buy, with ADC.PR.A preferred shares upgraded to Strong Buy for compelling risk-adjusted income. ADC demonstrates resilient AFFO growth and prudent capital recycling and maintains a 99.8% leased portfolio, supporting a sustainable 4.94% dividend yield. Rising capital costs could challenge immediate acquisition accretion, but long-term compounding from rent escalators and selective investments…
View source ↗ - Newsglobenewswire.com·31d ago·Negative
BioNTech Advances Phase 3 Clinical Trial of Pumitamig in Combination with Gilead's TROP2-Directed ADC Sacituzumab Govitecan in Triple-Negative Breast Cancer MAINZ, Germany, October 22, 2026 – BioNTech SE (Nasdaq: BNTX, “BioNTech”) today announced a clinical trial collaboration and supply agreement with Gilead Sciences Inc. (“Gilead”) to evaluate pumitamig in combination with the TROP2-directed antibody-drug conjugate (“ADC”) sacituzumab govitecan (Trodelvy®) as first-line treatment for patients …
View source ↗ - News (RSS)fool·31d ago·Positive
Agree Realty: 3 Key Takeaways for Long-Term Investors Development platform activity nearly doubled year-over-year, signaling a shift toward higher-yielding projects.
View source ↗ - Newsfool.com·31d ago·Neutral
Agree Realty: 3 Key Takeaways for Long-Term Investors Agree Realty reduced 2026 investment volume guidance to $1.6 billion. The company's retail portfolio reached 99.8% occupancy in the third quarter.
View source ↗ - News (RSS)fool·32d ago·Positive
Agree Realty (ADC) Q3 2026 Earnings Call Transcript CEO Joey Agree signals higher cap rates ahead as company culls lower-yield deals.
View source ↗ - News (Marketaux)seekingalpha.com·32d ago·Neutral
Agree Realty outlines $1.6B 2026 investment plan while targeting $100M-$150M dispositions (NYSE:ADC) Agree Realty outlines $1.6B 2026 investment plan while targeting $100M-$150M dispositions (NYSE:ADC)
View source ↗ - News (RSS)seekingalpha·32d ago·Neutral
Agree Realty outlines $1.6B 2026 investment plan while targeting $100M-$150M dispositions
View source ↗ - News (RSS)seekingalpha·32d ago·Positive
Agree Realty Corporation (ADC) Q3 2026 Earnings Call Transcript
View source ↗ - Newsmarketbeat.com·32d ago·Neutral
What Agree Realty (ADC) Said on Its Q3 Earnings Call Agree Realty NYSE: ADC reported third-quarter 2026 core funds from operations and adjusted funds from operations of $1.15 per share, each up 4.9% from the prior-year quarter, while maintaining portfolio occupancy of 99.8%.
View source ↗ - Newsseekingalpha.com·32d ago·Positive
Agree Realty Corporation (ADC) Q3 2026 Earnings Call Transcript Agree Realty Corporation ( ADC ) Q3 2026 Earnings Call October 21, 2026 9:00 AM EDT Company Participants Reuben Treatman - Senior Director of Corporate Finance Joey Agree - President, CEO & Director Peter Coughenour - CFO, Secretary & Investor Relations Professional Conference Call Participants Richard Hightower - Barclays Bank PLC, Research Division Michael Goldsmith - UBS Investment Bank, Research Division Nicholas Joseph - Citigr…
View source ↗ - News (Marketaux)gurufocus.com·32d ago·Positive
ADC SWOT Analysis: Strong Growth Potential Revealed in 10-Q Filing On October 20, 2026, Agree [+150 characters]
View source ↗ - News (RSS)seekingalpha·32d ago·Neutral
Agree Realty: 7.3% Acquisitions, $75 Equity, And A $67 Stock
View source ↗ - Newsseekingalpha.com·33d ago·Neutral
Agree Realty: 7.3% Acquisitions, $75 Equity, And A $67 Stock Agree Realty Corporation delivered a respectable quarter, with AFFO and Core FFO slightly beating consensus estimates. ADC reduced full-year 2026 investment guidance from $1.7B to $1.6B while raising disposition targets to $100–$150M. Acquisitions remain accretive, with Q3 2026 deals averaging a 7.3% cap rate, comfortably above ADC's WACC.
View source ↗ - Newszacks.com·33d ago·Positive
Agree Realty (ADC) Beats Q3 FFO and Revenue Estimates Agree Realty (ADC) came out with quarterly funds from operations (FFO) of $1.15 per share, beating the Zacks Consensus Estimate of $1.14 per share. This compares to FFO of $1.1 per share a year ago.
View source ↗ - Newsseekingalpha.com·33d ago·Neutral
What To Watch This REIT Earnings Season Rate Shock: REITs enter earnings season on their back foot amid a renewed surge in long-term rates, facing a materially different cost-of-capital and financing environment than just three months ago. The rate surge is again stressing highly leveraged borrowers, particularly across private markets. Public REITs are better positioned, but remain exposed through refinancing, tenant credit, and equity valuations. Higher rates have brought an important silver l
View source ↗ - News247wallst.com·33d ago·Neutral
A $750,000 Dividend Portfolio Could Lose $13,920 a Year to Taxes. Here's the Roth Alternative Parking high-yield BDCs and REITs in a taxable account quietly hands the IRS a check every April, and most investors never calculate exactly how much they are giving away each year across their entire portfolio.
View source ↗ - News (RSS)businessinsider·33d ago·Neutral
Agree Realty Q3 2026 Earnings Preview
View source ↗ - 4chan /biz/biz·34d ago·Neutral
>>62799433 Agree. Imagine doing computer science when we have ai
View source ↗ - News (RSS)seekingalpha·34d ago·Neutral
Agree Realty Corporation After The Rate Hike: Buy, Hold, Or Sell?
View source ↗ - News247wallst.com·34d ago·Neutral
3 Dividend Stocks That Let You Collect Rent Without Becoming a Landlord Net lease REITs let you collect rent checks without fixing a single leaky faucet, but not all three of these monthly payers carry the same risks, growth rates, or tenant quality under the hood.
View source ↗ - Newsseekingalpha.com·34d ago·Neutral
Agree Realty Corporation After The Rate Hike: Buy, Hold, Or Sell? Agree Realty has crashed 17% despite strong fundamentals. Its fortress balance sheet limits the impact of rising rates. Insiders are buying heavily, even as the stock gets cheaper.
View source ↗ - Newsnewsfilecorp.com·34d ago·Neutral
Defence Therapeutics Wins Best Poster Award and Takes Center Stage at World ADC San Diego 2026, a Key Recognition in the Field Highlighting the Potential of Its Accum Platform Montreal, Quebec--(Newsfile Corp. - October 19, 2026) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a publicly traded biotechnology company developing next-generation precision oncology therapeutics using its proprietary Accum® drug-delivery platform, is pleased to announce …
View source ↗ - Newsseekingalpha.com·35d ago·Negative
Dividend Announcements: October 10-16, 2026 I track dividend announcements across 1,200+ stocks. This week, I'm highlighting 12 dividend increases and 2 specials. LECO stands out with a 10.13% dividend increase, the highest Quality Score (8.54), and a 30-year streak, though it trades at fair value. IBKR posted a 71.43% dividend hike and leads in Dividend Safety (9.2), but offers a low 0.73% forward yield and weak financial strength.
View source ↗ - Newsseekingalpha.com·35d ago·Positive
AI Reality Check, Inflation Stress Test U.S. equities stumbled as AI-bubble concerns overwhelmed otherwise resilient fundamentals, while September inflation ran hot but remained heavily energy-driven, complicating the Fed's path without clearly forcing an October hike. Treasuries rallied sharply despite hotter CPI and PPI, with the 2-Year reversing from 4.95% to 4.71% as dovish Fed signals and risk-off flows pushed October hike odds. Oil reemerged as the key macro pressure point, with WTI surgin
View source ↗ - News247wallst.com·36d ago·Neutral
5 Monthly Dividend Stocks Retirees Should Consider This Month Monthly bills arrive on a schedule that quarterly dividends cannot match, but five stocks pay 12 times a year with yields climbing as high as 6.65%. Two of them carry risks that could quietly shrink your paycheck before you notice.
View source ↗ - Newsglobenewswire.com·38d ago·Positive
Akari Therapeutics CEO Highlights Differentiated ADC Payload Strategy and Path Toward Clinical Development in New CEO Corner CEO Abizer Gaslightwala discusses Akari's novel PH1 payload strategy and execution priorities supporting AKTX-101's advancement toward planned Phase 1 clinical development in mid-2027
View source ↗ - News (RSS)seekingalpha·40d ago·Neutral
ADC.PRA Agree Realty Corp. - 4.25% PRF PERPETUAL USD 25 - Ser A 1/1000th declares $0.0885 dividend
View source ↗ - News (RSS)seekingalpha·40d ago·Neutral
Agree Realty raises monthly dividend by 3.4% to $0.271/share
View source ↗ - Newsglobenewswire.com·40d ago·Neutral
Akari Therapeutics Appoints Accomplished Oncology and ADC Deal Executive Vatnak Vat-Ho as Chief Business Officer to Drive Strategic Growth and Partnering Mr. Vat-Ho's appointment adds more than 20 years of oncology, biopharma and capital markets experience, including senior roles in transactions totaling more than $25 billion in aggregate value
View source ↗ - News247wallst.com·40d ago·Positive
Investors Love 5 Dividend Stocks That Pay Dependable Monthly Dividends Some REITs pay dividends quarterly, but these five send checks every single month, and their cash flow coverage tells a more interesting story than the yield numbers alone.
View source ↗ - Newsglobenewswire.com·40d ago·Neutral
VERAXA Biotech Presents in vivo Proof-of-Concept Data for BiTAC®-ADC Technology at World ADC Congress VERAXA Biotech presents first in vivo proof-of-concept for BiTAC®-ADC: tumor-selective activation with potent anti-tumor efficacy and improved safety.
View source ↗ - Newsprnewswire.com·41d ago·Positive
TI unveils new ADC to enable nanosecond-level telemetry and minimize downtime in AI data centers As AI workloads increase in volume and complexity, Texas Instruments is delivering the essential solutions needed to power, monitor and optimize AI data centers News highlights: TI's ADC34DSO75 is the industry's highest performance 3 gigasamples per second ADC, enabling 24/7, low-power, event-based remote monitoring at nanosecond resolution – thousands of times faster than what current solutions off…
View source ↗ - News (RSS)seekingalpha·42d ago·Neutral
Agree Realty: When Markets Turn Turbulent, This Is The REIT You Want To Own
View source ↗ - Newsseekingalpha.com·42d ago·Negative
Agree Realty: When Markets Turn Turbulent, This Is The REIT You Want To Own Agree Realty could be one of the most attractive REITs to own when market turbulence strikes. A closer look at ADC's dividend strategy reveals something that long-term income investors shouldn't overlook. Despite my higher risk tolerance, I'm considering building a position in ADC using an unconventional dividend reinvestment strategy.
View source ↗ - Newszacks.com·44d ago·Positive
Why Investors Need to Take Advantage of These 2 Finance Stocks Now Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
View source ↗ - News247wallst.com·44d ago·Neutral
How to Turn $100,000 Into Steady Monthly Income for Retirement More than half of Americans fear outliving their savings, and the usual advice to "just invest" ignores the mismatch between quarterly payouts and monthly bills.
View source ↗ - News (RSS)zerohedge·44d ago·Neutral
Why Texas Is Making Data Centers Wait Why Texas Is Making Data Centers Wait Authored by Ryan McEntush via Andreessen Horowitz (a16z), At the end of 2024, Texas' grid operator had 63 GW of large new customers in its queue. By this June, that figure reached 474 GW, more than five times record peak demand, about 90% of it data centers. Then Texas hit pause. What began as directions for data centers to pay for their own grid upgrades has since escalated to a freeze on all new permits. If you care ab
View source ↗ - News247wallst.com·45d ago·Neutral
5 Monthly Dividend Stocks That Could Turn Your Portfolio Into a Second Paycheck Some dividends are backed by nothing more than last quarter's earnings, but a handful of companies collect rent, regulated utility bills, and trash pickup fees under contracts that make next year's cash flow visible before the year even begins.
View source ↗ - Newsprnewswire.com·45d ago·Negative
ADC Therapeutics Announces Comprehensive Strategic Financial Restructuring Marking Key Capital Structure Improvements $86.6 Million Private Placement announced, with participation from new and existing investors, extending expected cash runway into 2029 HealthCare Royalty financing agreement amended, removing change-of-control payment Senior secure loan refinanced, decreasing principal to $50M with bullet payment in August 2029 and no minimum liquidity LAUSANNE, Switzerland, Oct. 8, 2026 /PRNe…
View source ↗ - News247wallst.com·45d ago·Neutral
Realty Income or Agree Realty: If I Could Only Collect One Monthly Dividend Until Retirement, It Would Be This One Both Realty Income and Agree Realty pay monthly dividends, own net lease properties, and have pulled back sharply in recent weeks, but holding the wrong one through retirement could cost you decades of compounding growth.
View source ↗ - News247wallst.com·46d ago·Neutral
3 Monthly Dividend Payers That Could Replace an October Paycheck Monthly dividends sound like a paycheck replacement, but the schedule is the easy part. Three REITs with October checks on the calendar reveal just how different safety, growth, and risk can look behind identical payment frequencies.
View source ↗ - 4chan /biz/biz·47d ago·Positive
>>62756864 Agree to disagree then I guess…he makes more sense to me than anyone else just sayin…he has one of the best reputations, no where near crypto Michele
View source ↗ - 4chan /biz/biz·48d ago·Neutral
>>62755845 Based boomers. Agree.
View source ↗ - Newsprnewswire.com·48d ago·Negative
TuHURA Biosciences Receives Key U.S. Patent for its Groundbreaking Delta Opioid Receptor (DOR) Antibody Drug Conjugate (ADC) Technology Patent discloses uses beyond ADCs, including autologous or allogeneic adoptive cellular immunotherapies like CAR-T, Tregs or TIL cell therapies TAMPA, Fla., Oct. 5, 2026 /PRNewswire/ -- TuHURA Biosciences, Inc. (NASDAQ:HURA) ("TuHURA" or the "Company"), a Phase 3 immuno-oncology company developing novel therapeutics to overcome resistance to cancer immunotherap…
View source ↗ - Newsglobenewswire.com·48d ago·Neutral
Crescent Biopharma Announces FDA Clearance of IND Application for CR-002, a PD-L1-targeted Topoisomerase Inhibitor ADC, for the Treatment of Solid Tumors Phase 1/2 APOLLO global clinical trial to evaluate CR-002 in multiple solid tumor types, including non-small cell lung cancer (NSCLC) and head and neck squamous cell carcinoma (HNSCC), on track to initiate in the fourth quarter of 2026
View source ↗ - News247wallst.com·52d ago·Positive
Rates Are Hammering REITs. These 5 Dividends Are Built to Hold Up The 10-year Treasury yield just hit a year-long high and dragged every one of these net lease REITs down with it, but falling share prices and failing dividends are not the same thing, and the difference matters more right now
View source ↗ - Newsnewsfilecorp.com·52d ago·Negative
Defence Therapeutics to Take the Stage at World ADC San Diego to Discuss the Next Frontier in Antibody-Drug Conjugates Montreal, Quebec--(Newsfile Corp. - October 1, 2026) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a publicly traded biotechnology company developing next-generation precision oncology therapeutics using its proprietary Accum® platform, is pleased to announce its participation in the 17th World ADC San Diego, taking place October …
View source ↗ - News247wallst.com·53d ago·Negative
5 Safest High-Yield Monthly Dividend Stocks Retirees Trust A 10-year Treasury sitting at a 52-week high just made dividend investing a lot harder, yet five monthly payers are still fighting for retirees' portfolios with yields, coverage ratios, and dividend growth records that demand a closer look.
View source ↗ - Newsglobenewswire.com·53d ago·Neutral
Bone Neoplasms - Market Insights, Epidemiology, and 7MM Forecast - 2036 | Precision Oncology and ADC Pipelines Unlock Strategic Growth Opportunities Through 2036 Dublin, Sept. 30, 2026 (GLOBE NEWSWIRE) -- "Bone Neoplasms - Market Insight, Epidemiology, and Market Forecast - 2036" has been added to ResearchAndMarkets. com's offering. The bone-neoplasms market is expected to maintain steady growth during the forecast period from 2026-2036. Key market drivers include the rising incidence of primary…
View source ↗ - 4chan /biz/biz·54d ago·Positive
>>62735526 Agree. Be a better man. Unfortunately I love gambling.
View source ↗ - 4chan /biz/biz·56d ago·Neutral
>>62730403 >Fire the CEO, $2 menu, Agree, but the company is running with a idiot in charge and going with lynchs saying you need to be ok being in a company a idiot can run
View source ↗ - Newsseekingalpha.com·60d ago·Negative
REITs Were Sold As Set-And-Forget Income, That Era May Be Over Many REITs are repriced to the downside and offer better yields. Yet this is just optics, as the underlying problem is very significant. The issue I see is that at the current valuations and market dynamics, REITs can't (or should not) be considered solid passive income investments.
View source ↗
Earnings
Tue, Feb 9(in 3 months)
Consensus estimate $0.49 per share
Typical surprise -0.1% (median, so one quarter with a near-zero estimate can't distort it)
- Tue, Oct 20$1.15 vs $0.47beat
- Thu, Jul 30$0.44 vs $0.48miss
- Tue, Apr 21$0.50 vs $0.48beat
- Tue, Feb 10$0.47 vs $0.47miss
- Tue, Oct 21$0.45 vs $0.45beat
- Thu, Jul 31$0.44 vs $0.45miss
Estimates and results for ADC via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by ADC officers and directors.
- Bought
- $17.3m
- Sold
- —
25 trades
0 trades
- Erlich Craigbought
- Rakolta John Jrbought
- Agree Joeybought
- Rakolta John Jrbought
- Rakolta John Jrbought
- Rakolta John Jrbought
- Agree Richardbought
- Rakolta John Jrbought
75 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.
Congress trades
- Josh Gottheimerhouse · NJ05 · disclosed Jul 8, 2026 (37d later)Sell$1,001 - $15,000
- Gilbert Cisneroshouse · CA31 · disclosed Feb 13, 2026 (29d later)Sell$15,001 - $50,000
- Lisa C. McClainhouse · MI09 · disclosed Oct 22, 2025 (27d later)Sell$1,001 - $15,000
- Lisa C. McClainhouse · MI09 · disclosed Sep 15, 2025 (33d later)Buy$1,001 - $15,000
- Lisa C. McClainhouse · MI09 · disclosed Aug 13, 2025 (63d later)Buy$1,001 - $15,000
- Lisa C. McClainhouse · MI09 · disclosed Aug 13, 2025 (57d later)Sell$1,001 - $15,000
- Josh Gottheimerhouse · NJ05 · disclosed May 14, 2025 (35d later)Sell$1,001 - $15,000
- Josh Gottheimerhouse · NJ05 · disclosed May 15, 2024 (30d later)Buy$1,001 - $15,000
- Josh Gottheimerhouse · NJ05 · disclosed Apr 7, 2024 (24d later)Sell$1,001 - $15,000
- Daniel Goldmanhouse · NY10 · disclosed Aug 13, 2023 (32d later)Sell$1,001 - $15,000
- Gilbert Cisneroshouse · CA31 · disclosed Oct 14, 2020 (15d later)Buy$1,001 - $15,000
- Gilbert Cisneroshouse · CA31 · disclosed Aug 19, 2020 (20d later)Buy$1,001 - $15,000
- Josh Gottheimerhouse · NJ05 · disclosed Aug 10, 2020 (19d later)Buy$1,001 - $15,000
- Van Taylorhouse · TX03 · disclosed Apr 15, 2019 (21d later)Sell$1,001 - $15,000
- Susan Margaret Collinssenate · ME · disclosed May 16, 2014 (9d later)Sell$1,001 - $15,000
Self-reported filings, amounts as brackets. Via Senate/House disclosures.
